Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q4 Earnings Expected to DeclineZacks Investment Research • 02/10/21
Ironwood CEO Steps Down Months After Clinical Trial Failure, Names Thomas McCourt As Interim Chief ExecutiveBenzinga • 02/09/21
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update CallBusiness Wire • 02/03/21
Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/05/21
Ironwood (IRWD) Up 19.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/05/20
Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare ConferenceBusiness Wire • 11/06/20
Ironwood Pharmaceuticals (IRWD) Tops Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/06/20
Ironwood Pharmaceuticals Reports Strong Third Quarter 2020 Results and Increases Full Year 2020 Financial GuidanceBusiness Wire • 11/05/20
Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of DirectorsBusiness Wire • 11/05/20
Ironwood Pharmaceuticals (IRWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/29/20
Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy AssessmentBusiness Wire • 09/29/20
Surging Earnings Estimates Signal Upside for Ironwood (IRWD) StockZacks Investment Research • 08/26/20
Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Peter Ingram on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20